Finance

Lists
HLUN-B:CPH
H Lundbeck A/S Class B
47,80 DKK
0,00%
(0,00) 1D
16 հոկ, 17:00:00 GMT+2  ·   DKK
All symbols
SymbolPriceChange% Change
Generating top insights for HLUN-B...
Open
47,74 DKK
High
48,10 DKK
Low
47,46 DKK
Mkt. cap
47,05 մլրդ
Avg. vol.
746,79 հզր
Volume
0,00
52-wk high
48,10 DKK
52-wk low
35,30 DKK
Shares outstanding
796,59 մլն
No. of employees
5 հզր
Open
47,74 DKK
High
48,10 DKK
Low
47,46 DKK
Mkt. cap
47,05 մլրդ
Avg. vol.
746,79 հզր
Volume
0,00
52-wk high
48,10 DKK
52-wk low
35,30 DKK
Shares outstanding
796,59 մլն
No. of employees
5 հզր
News stories
From web sources and news partners
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class B
CEOCharl Van Zyl
Employees5 հզր
Founded1915
Headquarters-
Sector-
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
6,28 մլրդ
6,09 մլրդ
7,12 մլրդ
6,46 մլրդ
Cost of goods sold
846,00 մլն
1,24 մլրդ
1,30 մլրդ
1,27 մլրդ
Cost of revenue
846,00 մլն
1,24 մլրդ
1,30 մլրդ
1,27 մլրդ
Research and development expenses
1,16 մլրդ
820,00 մլն
1,38 մլրդ
1,43 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,15 մլրդ
2,54 մլրդ
2,13 մլրդ
2,28 մլրդ
Operating expense
3,31 մլրդ
4,36 մլրդ
3,52 մլրդ
3,70 մլրդ
Total operating expenses
4,16 մլրդ
5,60 մլրդ
4,82 մլրդ
4,96 մլրդ
Operating income
2,12 մլրդ
490,00 մլն
2,31 մլրդ
1,50 մլրդ
Other non operating income
-
-32,00 մլն
-
-
EBT including unusual items
1,41 մլրդ
360,00 մլն
2,13 մլրդ
1,47 մլրդ
EBT excluding unusual items
1,90 մլրդ
567,00 մլն
2,28 մլրդ
1,47 մլրդ
Income tax expense
311,00 մլն
387,00 մլն
468,00 մլն
323,00 մլն
Effective tax rate
22,03%
107,50%
22,01%
21,96%
Other operating expenses
-
997,00 մլն
-
-11,00 մլն
Net income
1,10 մլրդ
-27,00 մլն
1,66 մլրդ
1,15 մլրդ
Net profit margin
17,53%
-0,44%
23,27%
17,76%
Earnings per share
1,44
0,94
2,16
1,54
Interest and investment income
-
199,00 մլն
-
-
Interest expense
-219,00 մլն
-83,00 մլն
-29,00 մլն
-27,00 մլն
Net interest expenses
-219,00 մլն
116,00 մլն
-29,00 մլն
-27,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
2,55 մլրդ
956,00 մլն
2,78 մլրդ
1,98 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps